The Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from these APIs.
A notification issued by Directorate General of Foreign Trade, M/o Commerce and Industry says that the restrictions will come into immediate effect and until further orders. The notification covers following APIs and formulations made from these APIs:
1. Paracetamol, 2. Tinidazole, 3. Metronidazole, 4. Acyclovir, 5. Vitamin B1, 6. Vitamin B6, 7. Vitamin B12, 8. Progesterone, 9. Chloramphenicol, 10. Erythromycin Salts, 11. Neomycin, 12. Clindamycin Salts and 13. Ornidazole.
Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhavan
New Delhi
Notification No. 50/2015-2020-DGFT
New Delhi, Dated: 03rd March, 2020
Subject: – Amendment in Export Policy of APIs and formulations made from these APIs
S.O. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended. read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes amendment, with immediate effect in Chapter 29(Organic Chemicals) and Chapter 30 (Pharmaceutical) of the Schedule 2 of the ITC (HS) Export Policy 2018, by inclusion of items, as indicated in the Table below:
| S.No | ITC HS Codes | Description | Present Policy | Revised Policy |
| 146 A | 29222933 | Paracetamol | Free | Restricted |
| 146 B | 29332910 | Tinidazole | ||
| 146 C | 29332920 | Metronidazole | ||
| 146 D | 29335990 | Acyclovir | ||
| 146E | 29362210 | Vitamin B1 | ||
| 146 F | 29362500 | Vitamin B6 | ||
| 146 G | 29362610 | Vitamin B12 | ||
| 146 H | 29372300 | Progesterone | ||
| 146 1 | 29414000 | Chloramphenicol | ||
| 146 J | 29415000 | Erythromycin Salts | ||
| 146 K | 29419050 | Neomycin | ||
| 146 L | 29419090 | Clindamycin Salts | ||
| 146 M | 29420090 | Ornidazole | ||
| 156 A | 30042050 | Formulations made of Chloramphenicol | ||
| 156 B | 30042061 | Formulations made of Erythromycin Salts | ||
| 156 C | 30042095 | Formulations made or Clindamycin Salts | ||
| 156 D | 30043919 | Formulations made of Progesterone | ||
| 156 E | 30045032 | Formulations made of Vitamin B1 | ||
| 156 F | 30045032 | Formulations made of Vitamin B12 | ||
| 156G | 30045039 | Formulations made of Vitamin B6 | ||
| 156H | 30049015 | Formulations made of Neomycin | ||
| 156I | 30049021 | Formulations made of Ornidazole | ||
| 156J | 30049022 | Formulations made of Metronidazole | ||
| 156K | 30049023 | Formulations made of Tinidazole | ||
| 156L | 30049099 | Formulations made of Acyclovir | ||
| 156M | 30049099 | Formulations made of Paracetamol |
2. Effect of this Notification:
Export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from these APIs under the ITC HS Codes mentioned against each is hereby ‘restricted’, with immediate effect and till further orders.
(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in
(Issued from File No. 01/91/180/24/AM20/EC)